BIS vs. BITO
BIS (ProShares UltraShort Nasdaq Biotechnology) and BITO (ProShares Bitcoin Strategy ETF) are both exchange-traded funds - BIS is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (-200%), while BITO is a Cryptocurrency fund actively managed by ProShares. BIS is passively managed, while BITO is actively managed. Over the past 3 years, BIS returned -24.98%/yr vs 18.00%/yr for BITO. At a correlation of -0.32, they often move in opposite directions. Both charge a 0.95% expense ratio.
Performance
BIS vs. BITO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BIS achieves a -17.93% return, which is significantly higher than BITO's -29.93% return.
BIS
- 1D
- -1.74%
- 1M
- -10.00%
- YTD
- -17.93%
- 6M
- -14.94%
- 1Y
- -55.93%
- 3Y*
- -24.98%
- 5Y*
- -14.70%
- 10Y*
- -26.06%
BITO
- 1D
- -3.31%
- 1M
- -18.05%
- YTD
- -29.93%
- 6M
- -30.03%
- 1Y
- -42.09%
- 3Y*
- 18.00%
- 5Y*
- —
- 10Y*
- —
BIS vs. BITO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | -17.93% | -45.95% | 4.79% | -6.54% | -2.14% | 2.76% |
BITO ProShares Bitcoin Strategy ETF | -29.93% | -11.19% | 104.45% | 137.33% | -63.91% | -29.31% |
Correlation
The correlation between BIS and BITO is -0.30, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.30 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.27 |
Correlation (All Time) Calculated using the full available price history since Oct 19, 2021 | -0.32 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BIS vs. BITO — Risk / Return Rank
BIS
BITO
BIS vs. BITO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares UltraShort Nasdaq Biotechnology (BIS) and ProShares Bitcoin Strategy ETF (BITO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| BIS | BITO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.43 | ||
| Sortino ratioReturn per unit of downside risk | -0.96 | ||
| Omega ratioGain probability vs. loss probability | 0.75 | 0.85 | -0.10 |
| Calmar ratioReturn relative to maximum drawdown | -1.02 | -0.80 | -0.22 |
| Martin ratioReturn relative to average drawdown | -1.39 | -1.35 | -0.04 |
Loading charts...
Drawdowns
BIS vs. BITO - Drawdown Comparison
The maximum BIS drawdown since its inception was -99.87%, which is greater than BITO's maximum drawdown of -77.86%. Use the drawdown chart below to compare losses from any high point for BIS and BITO.
Loading charts...
Drawdown Indicators
| BIS | BITO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.87% | -77.86% | -22.01% |
Max Drawdown (1Y)Largest decline over 1 year | -55.07% | -53.10% | -1.97% |
Max Drawdown (3Y)Largest decline over 3 years | -67.92% | -53.10% | -14.82% |
Max Drawdown (5Y)Largest decline over 5 years | -75.59% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -95.40% | — | — |
Current DrawdownCurrent decline from peak | -99.87% | -51.67% | -48.20% |
Average DrawdownAverage peak-to-trough decline | -90.04% | -36.86% | -53.18% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 41.32% | 31.28% | +10.04% |
Volatility
BIS vs. BITO - Volatility Comparison
ProShares UltraShort Nasdaq Biotechnology (BIS) has a higher volatility of 13.79% compared to ProShares Bitcoin Strategy ETF (BITO) at 12.79%. This indicates that BIS's price experiences larger fluctuations and is considered to be riskier than BITO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BIS | BITO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.79% | 12.79% | +1.00% |
Volatility (6M)Calculated over the trailing 6-month period | 32.10% | 34.39% | -2.29% |
Volatility (1Y)Calculated over the trailing 1-year period | 40.51% | 44.08% | -3.57% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.80% | 55.02% | -11.22% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 46.26% | 55.02% | -8.76% |
BIS vs. BITO - Expense Ratio Comparison
Both BIS and BITO have an expense ratio of 0.95%.
Dividends
BIS vs. BITO - Dividend Comparison
BIS's dividend yield for the trailing twelve months is around 5.61%, less than BITO's 71.07% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | 5.61% | 5.25% | 3.73% | 1.75% | 0.00% | 0.00% | 0.45% | 2.11% | 0.37% |
BITO ProShares Bitcoin Strategy ETF | 71.07% | 78.29% | 61.59% | 15.14% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
BIS and BITO have a correlation of -0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BIS has higher volatility (13.79%) compared to BITO (12.79%). In terms of maximum drawdown, BIS dropped -99.87% vs BITO's -77.86%.
On 3-year performance, BITO leads with 18.00% vs -24.98% for BIS. Both ETFs have the same 0.95% expense ratio. On volatility, BITO has been the lower-risk option at 12.79%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, BITO has performed better with a 18.00% return vs -24.98%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
BIS and BITO have the same expense ratio: 0.95% per year.
BITO has the higher dividend yield at 71.07%, compared with 5.61% for BIS.
BIS is categorized as Leveraged Equities, while BITO is Cryptocurrency.
BITO currently has the higher Sharpe Ratio (-0.96 vs -1.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BIS and BITO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer